Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients

Osteoporosis International

Volumn 25, Issue 3, 2014, Pages 1071-1079

  Casado, J L ^a   Banon S ^a   Andres R ^a   Perez Elias M J ^a   Moreno, A ^a   Moreno, S ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Bone mineral density; Chronic kidney disease; Dual energy X ray absorptiometry; HIV; Secondary hyperparathyroidism; Secondary osteoporosis; Viral hepatitis; Vitamin D

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; BONE DENSITY; CD4 LYMPHOCYTE COUNT; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HIV INFECTIONS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PREVALENCE; RISK FACTOR; SPAIN; VERY ELDERLY; VIROLOGY;

ABSORPTIOMETRY, PHOTON; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BONE DENSITY; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; SPAIN;

EID: 84894580966     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2506-3     Document Type: Article

References (42)

1. Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, D'Arminio Monforte A, Fox Z, Lundgren JD, EuroSIDA study group (2002) Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 16:1663-1671
2. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63-F67
3. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE (2006) HIV infection and bone mineral density in middle aged women. Clin Infect Dis 42:1014-1020
4. Jones S, Restrepo D, Kasowitz A, Korenstein D, Wallenstein S, Schneider A, Keller MJ (2008) Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporos Int 19:913-918
5. Dolan SE, Huang JS, Killilea KM, Sullivan MP, Aliabadi N, Grinspoon S (2004) Reduced bone density in HIV-infected women. AIDS 18:475-483
6. Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20:2165-2174
7. Triant VA, Brown TT, Lee H, Grinspoon SK (2008) Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 93:3499-3504
8. Young B, Dao CN, Buchacz K, Baker R, Brooks JT (2011) Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 52:1061-1068
9. Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, da Silva BA (2009) Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr 51:554-561
10. Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, Katlama C, Costagliola D; ANRS 121 Hippocampe study group (2009) Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS 23:817-824
11. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P (2003) Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482-490
12. Inaba M (2004) Secondary osteoporosis: thyrotoxicosis, rheumatoid arthritis, and diabetes mellitus. J Bone Miner Metab 22:287-292
13. Crum NF, Furtek KJ, Olson PE, Amling CL, Wallace MR (2005) A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post- HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDs 19:655-671
14. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1-S130
15. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929-1936
16. Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, Downs RW Jr; International Society for Clinical Densitometry (2004) Official positions of the International Society for Clinical Densitometry. J Clin Endocrinol Metab 89:3651-3655
17. World Health Organization (2007) Assessment of osteoporosis at the primary health care level. WHO, Geneva. www.who.int/chp/topics/rheumatic/en/ index.html. Accessed May 2013
18. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467-475
19. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM (1993) Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341: 72-75
20. Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M (2008) Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int 19:991-999
21. Deutschmann HA, Weger M, Weger W, Kotanko P, Deutschmann MJ, Skrabal F (2002) Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med 252:389-397
22. Johnson BE, Lucasey B, Robinson RG, Lukert BP (1989) Contributing diagnoses in osteoporosis. The value of a complete medical evaluation. Arch Intern Med 149:1069-1072
23. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431-4437
24. Bours SPG, van Geel TA, Geusens P, Janssen MJ, Janzing HM, Hoffland GA, Willems PC, van den Bergh JP (2011) Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab 96:1360-1367
25. Khosla S, Amin S, Orwoll E (2008) Osteoporosis in men. Endocr Rev 29:441-464
26. Bolland MJ, Grey AB, Gamble GD, Reid IR (2007) Clinical review: low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab 92:4522-4528
27. Chew NS, Doran PP, Powderly WG (2007) Osteopenia and osteoporosis in HIV: pathogenesis and treatment. Curr Opin HIV AIDS 2:318-323
28. Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, McCloskey EV, Mellstrom D, Melton LJ 3rd, Pols HA, Reeve J, Silman AJ, Tenenhouse A (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029-1037
29. Ramayo E, Gonzalez-Moreno MP, Macias J, Cruz-Ruíz M, Mira JA, Villar-Rueda AM, García-García JA, Gómez-Mateos JM, Lozano F, Pineda JA (2005) Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res Hum Retrovir 21:915-921
30. Liu H, Paige NM, Goldzweig CL, Wong E, Zhou A, Suttorp MJ, Munjas B, Orwoll E, Shekelle P (2008) Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med 148:685-701
31. Rouillard S, Lane NE (2001) Hepatic osteodystrophy. Hepatology 33:301-307
32. Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC (2012) Association between chronic hepatitis C virus infection and bone mineral density. Calcif Tissue Int 91:423-429
33. Lo Re V, Guaraldi G, Leonard MD, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P (2009) Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS 23:2191-2198
34. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, Myers L, Melbourne K, Ha B, Sax PE (2011) Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224 s, a substudy of ACTG A5202. J Infect Dis 203:1791-1801
35. Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, Thompson M, Grant R, Pathak S, O'Hara B, Gvetadze R, Chillag K, Grohskopf L, Buchbinder SP (2011) Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PloS One 6:e23688. doi: 10.1371/journal.pone.0023688
36. Isidro ML, Ruano B (2010) Bone disease in diabetes. Curr Diabetes Rev 6:144-155
37. Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, Yu Q, Zillikens MC, Gao X, Rivadeneira F (2012) Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 27:319-332
38. Sta RM, Li-Yu JT (2007) Investigation of the relationship between type 2 diabetes and osteoporosis using Bayesian inference. J Clin Densitom 10:386-390
39. The Endocrine Society. Summary from the 2nd Annual Andropause Consensus Meeting (Chevy Chase, MD): The Endocrine Society Continuing Medical Education Services, 2001
40. Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG (2009) Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly active antiretrovial therapy. Eur J Med Res 14:59-64
41. Grinspoon S (2005) Androgen deficiency and HIV infection. Clin Infect Dis 41:1804-1805
42. Nickolas TL, Leonard MB, Shane E (2008) Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721-731